Drugs
US President Donald Trump has vowed to drastically reduce pharmaceutical prices in the United States by implementing a "Most Favoured Nation" policy, where the cost of prescription drugs sold in the US would be pegged to the lowest price paid by other countries for the same drug. Trump
Trump, Donald
The US and China announced a surprise agreement to slash reciprocal tariffs by 115% and pause mutual tariffs for 90 days. This breakthrough comes as President Trump also announced plans to slash generic drug prices, a move contested by pharma companies. The agreement will reduce US tariffs on China from
Trump, Donald
India's $30 billion pharma exports to the US, accounting for over a third of its annual exports, are poised to be severely impacted by US President Donald Trump's decision to cut the prices of prescription drugs by 30-80%. The move is likely to make shipments unviable
Trump, Donald
President Trump signed an executive order on Monday, aiming to reduce U.S. prescription drug prices up to 90%. The order, which Trump announced at the White House, ties what government pays for drugs to the lowest prices paid by other economically advanced countries through a most favored nation (MFN)
Americans
President Donald J. Trump has signed a new Executive Order aimed at addressing the long-standing issue of disparate drug pricing in the US, where Americans pay significantly more for prescription drugs than citizens in other developed countries. The order, which introduces a "Most-Favored-Nation" (MFN) pricing model, targets unfair
Drugs
Editas Medicine, a pioneering gene editing company, is making significant progress towards the clinic with its in vivo medicines in preclinical development for people living with serious diseases. At the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), the company will present five abstracts, including
Drugs
President Trump's executive order aims to restore progress made during his first term to deliver lower prescription drug prices to American patients, which was undone by the Biden Administration. The order calls for various measures to reduce costs, promote competition, and improve innovation in the pharmaceutical industry. This
Drugs
As President Trump moves closer to imposing tariffs on imported medicines, experts warn that this could lead to increased costs, shortages of critical drugs, and a harsh backlash from patients and lawmakers. The U.S. relies heavily on imports, with many drugs manufactured in countries like China and India, where
Drugs
President Trump's latest executive order on reducing pharmaceutical costs is not a new initiative, but rather a revival of policies from his first term and changes to programs started during the Biden administration. The order's implementation details are shrouded in uncertainty, but polling consistently shows that
Drugs
Hong Kong's Secretary for Health, Prof Lo Chung-mau, has announced the expansion of the "1+" mechanism for drug registration and approval from November, aiming to provide patients with more choices of drugs at lower costs. The new mechanism will cover all new chemical entities, including vaccines
Attention deficit hyperactivity disorder
The Tasmanian Government has commenced changes to make it easier for specialists and GPs to prescribe ADHD medications in line with its 100-day plan. This modification allows specialists and GPs with expertise in ADHD and appropriate training to authorise medication prescriptions for up to three years, an increase from the
Attention deficit hyperactivity disorder
The Tasmanian Government has commenced changes to make it easier for specialists and GPs to prescribe Attention Deficit Hyperactivity Disorder (ADHD) medications. According to the Department of Health, the changes will allow specialists and GPs with Special Interests in ADHD and the appropriate training to prescribe medications for up to
